Literature DB >> 15071066

Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient.

Imad Dibo1, Satish K Pillai, Howard S Gold, Maria R Baer, Meir Wetzler, James L Slack, Peggy A Hazamy, Donna Ball, Chiu Bin Hsiao, Philip L McCarthy, Brahm H Segal.   

Abstract

We report a linezolid-resistant Enterococcus faecalis infection in a cord blood stem cell transplant recipient previously treated with linezolid for bloodstream infections by vancomycin-resistant enterococci. Sequencing showed a G2576U mutation in the 23S rRNA gene. Because of the important niche of linezolid in cancer treatment, linezolid-resistant E. faecalis is noteworthy.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15071066      PMCID： PMC387622          DOI： 10.1128/JCM.42.4.1843-1845.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

1.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors:  C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

2.  Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium.

Authors:  Inmaculada A Herrero; Nicolas C Issa; Robin Patel
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

3.  Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.

Authors:  S H Marshall; C J Donskey; R Hutton-Thomas; R A Salata; L B Rice
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

4.  Linezolid-resistant enterococci: report of the first isolates in the United Kingdom.

Authors:  Cressida Auckland; Louise Teare; Fiona Cooke; Mary E Kaufmann; Marina Warner; Graeme Jones; Kathy Bamford; Helen Ayles; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2002-11       Impact factor: 5.790

5.  Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.

Authors:  A P Johnson; L Tysall; M V Stockdale; N Woodford; M E Kaufmann; M Warner; D M Livermore; F Asboth; F J Allerberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-09-13       Impact factor: 3.267

Review 6.  Linezolid Pharmacia Corp.

Authors:  J F Barrett
Journal:  Curr Opin Investig Drugs       Date:  2000-10

7.  Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients.

Authors:  M J Kuehnert; J A Jernigan; A L Pullen; D Rimland; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1999-10       Impact factor: 3.254

8.  Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center.

Authors:  H Hanna; J Umphrey; J Tarrand; M Mendoza; I Raad
Journal:  Infect Control Hosp Epidemiol       Date:  2001-04       Impact factor: 3.254

9.  Surveillance of intestinal colonization and of infection by vancomycin-resistant enterococci in hospitalized cancer patients.

Authors:  Florence Moulin; Sandrine Dumontier; Patrick Saulnier; Elisabeth Chachaty; Cécile Loubeyre; Laurence Brugières; Antoine Andremont
Journal:  Clin Microbiol Infect       Date:  1996-02       Impact factor: 8.067

10.  Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS).

Authors:  Charles H Ballow; Douglas J Biedenbach; Flavia Rossi; Ronald N Jones
Journal:  Braz J Infect Dis       Date:  2002-06       Impact factor: 1.949
View more
  7 in total

1.  Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus.

Authors:  Nicole Wolter; Anthony M Smith; David J Farrell; William Schaffner; Matthew Moore; Cynthia G Whitney; James H Jorgensen; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis.

Authors:  Alexandre R Marra; Yvette Major; Michael B Edmond
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

3.  In vivo efficacy of a novel oxazolidinone compound in two mouse models of infection.

Authors:  Charles J Gill; George K Abruzzo; Amy M Flattery; Andrew S Misura; Ken Bartizal; Emily J Hickey
Journal:  Antimicrob Agents Chemother       Date:  2007-07-02       Impact factor: 5.191

Review 4.  Pharmacological issues of linezolid: an updated critical review.

Authors:  Antonello Di Paolo; Paolo Malacarne; Emanuele Guidotti; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

Review 5.  Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.

Authors:  Bhavarth S Shukla; Timothy P Gauthier; Ricardo Correa; Laura Smith; Lilian Abbo
Journal:  Int J Clin Pharm       Date:  2013-07-27

6.  Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis.

Authors:  Chao Qi; Xiaotian Zheng; Arlene Obias; Marc H Scheetz; Michael Malczynski; John R Warren
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

7.  The first linezolid-resistant Enterococcus faecium in India: High level resistance in a patient with no previous antibiotic exposure.

Authors:  Simit Kumar; Maitreyi Bandyoapdhyay; Mitali Chatterjee; Prabir Mukhopadhyay; Sumon Poddar; Parthajit Banerjee
Journal:  Avicenna J Med       Date:  2014-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.